Constitutive androstane receptor ligands modulate the anti-tumor efficacy of paclitaxel in non-small cell lung cancer cells.
<h4>Background</h4>Lung tumors are the leading cause of cancer deaths worldwide and paclitaxel has proven to be useful for patients with lung cancer, however, acquired resistance is a major problem. To overcome this problem, one promising option is the use of Constitutive Androstane Rece...
Guardado en:
Autores principales: | Heidge Fukumasu, Arina L Rochetti, Pedro R L Pires, Edson R Silva, Ligia G Mesquita, Ricardo F Strefezzi, Daniel D De Carvalho, Maria L Dagli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e564eb23803c4938b2a290a345db19ef |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Liquid biopsy based on small extracellular vesicles predicts chemotherapy response of canine multicentric lymphomas
por: Taismara K. Garnica, et al.
Publicado: (2020) -
Transportan in nanocarriers improves skin localization and antitumor activity of paclitaxel
por: Pepe D, et al.
Publicado: (2016) -
Calcium-sensing receptors signal constitutive macropinocytosis and facilitate the uptake of NOD2 ligands in macrophages
por: Johnathan Canton, et al.
Publicado: (2016) -
Targeted paclitaxel‐octreotide conjugates inhibited the growth of paclitaxel‐resistant human non‐small cell lung cancer A549 cells in vitro
por: Yanguo Liu, et al.
Publicado: (2021) -
HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma
por: Peng J, et al.
Publicado: (2020)